Close Menu

NEW YORK – BioSpyder Technologies on Wednesday filed a civil action in  US District Court for the Northern District of California seeking a declaratory judgement that the firm's TempO-Seq gene expression profiling assay does not infringe a patent held by HTG Molecular Diagnostics.

BioSpyder's actions relates to US Patent No. 8,741,564 held by HTG covering a quantitative nuclease protection assay (QNPA) and sequencing (QNPS) improvements. 

The Carlsbad, California-startup firm said that HTG has repeatedly and baselessly asserted that BioSpyder has infringed the '564 patent.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.